–
Статьи в журналах
-
- 2021 Analysis of the efficacy and safety of eribulin therapy in patients with HR$\mathplus$/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
- Kolyadina Irina V., Abidova Natalia R., Akopyan Arshak A., Antonova Galina V., Arapova Oksana I., Bobrova Elvira A., Bolotina Larisa V., Valiakhmetova Chulpan K., Vasilevskaya Anna V., Vladimirova Lyubov Y., Volkonskiy Mikhail V., Ganshina Inna P., Gudkova Irina E., Dergunov Alexandr S., Evstigneeva Irina V., Egurenkova Viktoria S., Emshanov Aleksei V., Zhukova Lyudmila G., Zueva Elena V., Karabina Elena V., Kolokolov James J., Kuzmicheva Svetlana V., Kuchevskaya Olesya A., Luev Ivan A., Markizova Elena V., Marfutov Vasily V., Medvedev Sergey P., Merzlikina Yulia I., Nersesova Tatyana A., Ovchinnikova Elena G., Orlova Svetlana A., Samaneva Natalia Y., Stativko Olesya A., Storozhakova Anna E., Stroyakovskiy Daniil L., Sultanbaev Alexander V., Tekeeva Asiat I., Fadeeva Natalia V., Fedorova Alina N., Shalaeva Oksana M., Shangina Irina A., Shirokova Oksana N., Shumskikh Alisa R., Yakubova Mariam Z.
- в журнале Современная онкология, издательство ООО «ММА «МедиаМедика» (Москва), том 23, № 1, с. 68-76 DOI